KK2 - You're not the only one. It doesn't make sense, does it, an "indication" being an illness for which a drug is prescribed.
I assume she means that the BTD is to develop ABL as a drug to prevent MACE (as she defines it, apparently including both stroke and CHF) in diabetics with ACS.
It would be nice to see the letter from the FDA.